U.S. RESEARCH ROUNDUP- Akoya Biosciences, Boston Beer Company, Victory Capital Holdings

May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akoya Biosciences, Boston Beer Company and Victory Capital Holdings on Tuesday.

HIGHLIGHTS

* Akoya Biosciences Inc : Canaccord Genuity cuts target price to $6

from $10

* Boston Beer Company Inc : Jefferies raises target price to $360 from

$335

* Fortrea Holdings Inc : Evercore ISI cuts target price to $31 from

$43

* Medical Properties Trust Inc : RBC cuts to sector perform from

outperform

* Victory Capital Holdings Inc : RBC raises target price to $56 from

$47

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Agilon Health Inc : Jefferies cuts target price to $5.75 from $6.5

* Akoya Biosciences Inc : BTIG cuts target price to $6 from $9

* Akoya Biosciences Inc : Canaccord Genuity cuts target price to $6 from $10

* Akoya Biosciences Inc : JP Morgan cuts target price to $7 from $10

* Applied DNA Sciences Inc : Maxim Group cuts to hold from buy

* Arcellx Inc : Evercore ISI initiates coverage with outperform rating; PT $85

* Aris Water Solutions Inc : Evercore ISI raises target price to $20 from $16

* Atlanticus Holdings Corp : Jefferies cuts target price to $40 from $50

* Biomarin Pharmaceutical : Evercore ISI initiates with outperform rating; PT $113

* Blue Owl Capital Corp : KBW cuts to market perform from outperform

* Boston Beer Company Inc : Jefferies raises target price to $360 from $335

* Boston Beer Company Inc : Jefferies raises to buy from hold

* Bridgebio Pharma : Evercore ISI initiates coverage with outperform rating; PT $50

* Brighthouse Financial Inc : KBW cuts target price to $48 from $50

* Caredx Inc : Raymond James cuts to market perform from outperform

* Caretrust REIT Inc : Jefferies raises target price to $28 from $27

* Chuy's Holdings Inc : Stifel cuts target price to $32 from $36

* Civista Bancshares Inc : D.A. Davidson cuts target price by $4 to $17

* Clearway Energy Inc : Evercore ISI raises target price to $30 from $25

* Compass Therapeutics Inc. : Jefferies cuts target price to $7 from $8

* Compass Therapeutics Inc. : Leerink Partners cuts target price to $10 from $11

* Constellation Brands Inc : Jefferies cuts target price to $311 from $314

* Definitive Healthcare Corp : Jefferies cuts target price to $10 from $12

* Emerson : Berenberg raises target price to $133 from $130

* Five Below Inc : Jefferies cuts target price to $200 from $215

* Fortrea Holdings Inc : Evercore ISI cuts target price to $31 from $43

* Fulcrum Therapeutics Inc : Leerink Partners raises target price to $16 from $14

* Green Plains Inc : Jefferies cuts target price to $37 from $45

* Inotiv Inc : Jefferies cuts target price to $3.75 from $11.5

* Inotiv Inc : Jefferies cuts to hold from buy

* Iovance Biotherapeutics Inc : Truist Securities cuts PT to $25 from $26

* Jackson Financial Inc : KBW cuts to market perform from outperform

* $Jackson Financial Inc(JXN-A)$ : KBW raises target price to $80 from $75

* Jeld-Wen Holding Inc : Jefferies cuts target price to $16 from $20

* Legend Biotech Corp : Jefferies raises target price to $94 from $93

* Legend Biotech Corp : RBC raises target price to $86 from $85

* Live Oak Bancshares Inc : Truist Securities raises target price to $40 from $38

* Madison Square Garden Entertainment Corp : Macquarie raises PT to $46 from $45

* Medical Properties Trust Inc : RBC cuts to sector perform from outperform

* Moderna : Evercore ISI initiates coverage with in line rating; price target $120

* National Health Investors Inc : Jefferies raises target price to $63 from $54

* Nelnet Inc : TD Cowen raises target price to $96 from $90

* Neurocrine Biosciences : Evercore ISI initiates with outperform rating; PT $175

* Neurogene Inc : Leerink Partners cuts target price to $45 from $46

* Novabay Pharmaceuticals Inc : Ascendiant Capital Markets cuts PT to $1.75 from $2

* Orange County Bancorp Inc : Stephens cuts target price to $53 from $56

* Palo Alto Networks Inc : Evercore ISI adds stock to its tactical underperform list

* Palo Alto Networks Inc : Evercore ISI cuts target price to $385 from $405

* Perspective Therapeutics : RBC initiates coverage With Outperform rating; PT $3

* Plains All American Pipeline LP : RBC raises target price to $18 from $17

* Planet Fitness Inc : JP Morgan raises target price to $78 from $68

* Planet Fitness Inc : JP Morgan raises to overweight from neutral

* Primerica Inc : KBW cuts target price to $255 from $260

* Regeneron Pharmaceuticals : Evercore ISI initiates coverage with outperform rating

* Regeneron Pharmaceuticals : Evercore ISI initiates coverage with PT $1150

* Roblox Corp : Roth MKM cuts target price to $35 from $55

* Roblox Corp : Roth MKM cuts to neutral from buy

* SLB : zephirin Group raises price objective to $59 from $57

* Sphere Entertainment Co : Macquarie cuts target price to $38 from $40

* Squarespace Inc : Raymond James cuts to market perform from outperform

* Taysha Gene Therapies Inc : Jefferies raises target price to $8 from $2

* Taysha Gene Therapies Inc : Jefferies raises to buy from hold

* Terreno Realty Corp : Jefferies raises target price to $89 from $87

* Territorial Bancorp Inc : KBW cuts target price to $9.66 from $10

* Trex Co Inc : JP Morgan raises target price to $95 from $93

* United Bankshares Inc : Stephens raises target price to $36 from $34

* Verb Technology Company : Ascendiant Capital Markets cuts PT to $4.50 from $5

* Verrica Pharmaceuticals Inc : Needham raises target price to $16 from $8

* Victory Capital Holdings Inc : RBC raises target price to $56 from $47

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))